Drag a card by its title · ⚙ to size, swap or remove

The company

Grace Therapeutics, Inc.

GRCE · Nasdaq

Health CareBiotechnologyNot moving yet

GRCE stood above a rising 150-day average in 26 of the last 52 weekly readings, and has been out of that trend for the last 26 weeks. It is 27.7% below that average now. Biotechnology: 15% of its 561 stocks in an uptrend (−17 points in four weeks); Health Care: 25% (−11 points in four weeks).

SEC filings

Statistics

Rotation: Not moving yet
Weeks in an uptrend: out for 26
Industry in uptrend: 15% -17 in 4 wk
Insider buys, 12 months: $941K
Insider sales, 12 months: $0
Officials’ trades on record: 0
Institutions holding: 31 (-3)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 26 of 52 weeks.

17 Apr – 16 Oct

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months18

Sale orders, 12 months0

Buyers · sellers2 · 0

Who	Did	Shares	Traded
Opaleye Management Inc.10% owner	bought	36,347at $1.89	16 Oct 2026filed 16 Oct 2026
Opaleye Management Inc.10% owner	bought	23,485at $1.95	15 Oct 2026filed 16 Oct 2026
Opaleye Management Inc.10% owner	bought	11,233at $1.93	14 Oct 2026filed 16 Oct 2026
Opaleye Management Inc.10% owner	bought	7,215at $2.02	12 Oct 2026filed 13 Oct 2026
Opaleye Management Inc.10% owner	bought	5,340at $2.04	9 Oct 2026filed 13 Oct 2026
Opaleye Management Inc.10% owner	bought	2,077at $2.02	8 Oct 2026filed 13 Oct 2026
Opaleye Management Inc.10% owner	bought	1,694at $2.06	5 Oct 2026filed 5 Oct 2026
Opaleye Management Inc.10% owner	bought	20,000at $2.07	2 Oct 2026filed 5 Oct 2026
Opaleye Management Inc.10% owner	bought	38,796at $2.04	1 Oct 2026filed 5 Oct 2026
Opaleye Management Inc.10% owner	bought	7,849at $2.09	29 Sep 2026filed 1 Oct 2026
Opaleye Management Inc.10% owner	bought	5,318at $2.10	23 Sep 2026filed 23 Sep 2026
Opaleye Management Inc.10% owner	bought	5,318at $2.10	23 Sep 2026filed 1 Oct 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders31-3 on the quarter

New · exited8 · 11

Reported value$8.6M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

Manager	Shares	Change
Cerity Partners LLCunchanged · filed 14 Aug 2026	849,055$1.9M	00.0%
Eversept Partners, LPadded · filed 14 Aug 2026	772,900$1.8M	+16,300+2.2%
BANK OF AMERICA CORPreduced · filed 14 Aug 2026	494,698$1.1M	-250.0%
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026	411,714$935K	+10,058+2.5%
CITADEL ADVISORS LLCadded · filed 14 Aug 2026	349,740$794K	+250,998+254.2%
Maven Securities LTDnew · filed 14 Aug 2026	200,000$454K	+200,000
Birchview Capital, LPadded · filed 14 Aug 2026	120,000$272K	+70,000+140.0%
CANTOR FITZGERALD, L. P.new · filed 14 Aug 2026	100,000$227K	+100,000
TWO SIGMA INVESTMENTS, LPnew · filed 14 Aug 2026	96,890$220K	+96,890
JANE STREET GROUP, LLCreduced · filed 14 Aug 2026	89,442$203K	-77,655−46.5%